Canada· CA-DIN-02528495
GLN-ATOVAQUONE
A atovaquone product containing atovaquone, registered in Canada by GLENMARK PHARMACEUTICALS CANADA INC.. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Atovaquone is registered in 11 of 19 countries.
Countries holding a registration under ATC P01AX06 (atovaquone), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Atovaquone · ATC P01AX06
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ATOVAQUONE
- Manufacturer
- GLENMARK PHARMACEUTICALS CANADA INC.
- Country
- Canada (CA)
- ATC code
- P01AX06
- ATC class
- Atovaquone
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
182 interactions on record for atovaquone.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atovaquone · interactions on record
182 records
- 8 severe
- 32 moderate
- 4 minor
- 133 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- EfavirenzJ05AG03severe
- PexidartinibL01EX15severe
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Atovaquone in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesatovaquoneGlenmark Pharmaceuticals Inc., USA
- SwedenAtovaquone Glenmark 150 mg/ml Oral suspensionGlenmark Arzneimittel GmbH
- United KingdomAtovaquone 750mg/5ml oral suspension sugar freeAlliance Healthcare (Distribution) Ltd
- BelgiumAtovaquone/Proguanil EG 250 mg - 100 mgOrifarm
- FranceATOVAQUONE BIOGARAN 750 mg/5mL, suspension buvableBIOGARAN
- NetherlandsAtovaquon Glenmark 750 mg/5 ml suspensie voor oraal gebruikGlenmark Arzneimittel GmbH
- GermanyAtovaquon GlenmarkGlenmark Arzneimittel Gmbh
- NorwayWellvone SuspensionGlaxoSmithKline
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Wellvone
- Germany · Atovaquon Glenmark, Wellvone
- Denmark · Atovaquone Glenmark
- Spain · Atovacuona Glenmark, Wellvone
- France · Atovaquone Biogaran, Wellvone
- United Kingdom (Northern Ireland) · Atovaquone Amarox, Atovaquone Glenmark Pharmaceuticals Europe
- Greece · Atovaquone Vocate, Wellvone
- Italy · Atovaquone Glenmark, Wellvone
- Luxembourg · Wellvone
- Netherlands · Atovaquon Glenmark, Wellvone
- Norway · Atovaquone Glenmark
- Portugal · Atovaquona Kabi, Wellvone
- Sweden · Atovaquone Glenmark, Wellvone
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/090df150-5ecb-4185-80b3-0539424f6387 GET /v1/drugs/090df150-5ecb-4185-80b3-0539424f6387?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02528495",
"form": "SUSPENSION",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "P01AX06",
"schedule": [
"Prescription"
],
"drug_code": "101772",
"strengths": [
"750 MG"
],
"ahfs_class": null,
"substances": [
"ATOVAQUONE"
],
"product_categorization": null
}See everything about atovaquone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.